MUNJAL SHROFF: Open Payments
NPI 1093862948 · SMYRNA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$35,292 in 166 payments from 22 companies in 2025. Trend: 2023 $57,837 · 2024 $37,641 · 2025 $35,292
Honoraria: $19,650Speaker / faculty: $11,250Food & beverage: $3,194Travel & lodging: $1,198
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 55 | $21,904 |
| ABBVIE INC. | 38 | $11,850 |
| HARMONY BIOSCIENCES LLC | 7 | $179 |
| Vanda Pharmaceuticals Inc. | 8 | $179 |
| Noven Therapeutics, LLC | 7 | $134 |
| Tris Pharma Inc | 6 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $110 |
| Otsuka America Pharmaceutical, Inc. | 5 | $107 |
| Neurocrine BioSciences, Inc. | 4 | $90 |
| Corium, LLC | 7 | $86 |
Products named: Auvelity, VRAYLAR, WAKIX, FANAPT, Sunosi, Xelstrym, Dyanavel XR, TRINTELLIX.
Industry payments across GA — which companies pay providers there.
